Market Cap 32.20B
Revenue (ttm) 4.66B
Net Income (ttm) 836.30M
EPS (ttm) N/A
PE Ratio 29.23
Forward PE 28.95
Profit Margin 17.94%
Debt to Equity Ratio 0.42
Volume 5,956,940
Avg Vol 5,346,788
Day's Range N/A - N/A
Shares Out 385.87M
Stochastic %K 98%
Beta 1.45
Analysts Strong Sell
Price Target $86.11

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with predi...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
Mobagri
Mobagri Aug. 4 at 2:06 PM
$DXCM https://www.marketscreener.com/news/argus-adjusts-price-target-on-dexcom-to-96-from-86-maintains-buy-rating-ce7f50deda80f320
0 · Reply
MaxDillon_
MaxDillon_ Aug. 3 at 10:53 PM
Wall Street Analyst Rating Updates: Key Target Shifts! • $DT: Cantor raises target to $47 (from $37), Overweight (Trading at $44.54) • $DXCM: Canaccord lifts target to $90 (from $82), Buy (Trading at $87.31). • $EBAY: Bernstein reiterates $115 Market Perform; Wells Fargo cuts target to $92 and downgrades to Underweight (Trading at $114.01). Diverging analyst sentiment creates key entry and exit divergences for smart capital.Are you buying the $DXCM momentum or shorting$EBAY's downgrade?
0 · Reply
Mobagri
Mobagri Aug. 3 at 3:40 PM
$DXCM we close at $89 today
1 · Reply
Mobagri
Mobagri Aug. 3 at 3:39 PM
$DXCM https://www.marketscreener.com/news/ubs-adjusts-price-target-on-dexcom-to-102-from-96-maintains-buy-rating-ce7f50d9da89f12d
0 · Reply
RobertMickey186
RobertMickey186 Aug. 3 at 2:47 PM
$JBL $ZTS $MLM $VG $DXCM Jabil benefits from electronics manufacturing, Zoetis leads animal health, Martin Marietta gains from construction demand, Venture Global benefits from LNG exports, and DexCom dominates continuous glucose monitoring.
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:49 PM
$DXCM https://www.marketscreener.com/news/rothschild-co-redburn-adjusts-price-target-on-dexcom-to-100-from-90-maintains-buy-rating-ce7f50d9db89f025
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:43 PM
$DXCM going towards $93 faster than I thought
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:08 PM
$DXCM yop
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:06 PM
$DXCM huge buying by investment funds
0 · Reply
m322m
m322m Aug. 2 at 8:38 PM
$DXCM best mode 💚
0 · Reply
Latest News on DXCM
DexCom price target raised to $96 from $86 at Argus

2026-08-04T13:21:04.000Z - 7 hours ago

DexCom price target raised to $96 from $86 at Argus


DexCom price target raised to $90 from $82 at Canaccord

2026-08-03T11:05:25.000Z - 1 day ago

DexCom price target raised to $90 from $82 at Canaccord


DexCom price target raised to $92 from $86 at Deutsche Bank

2026-07-31T12:56:52.000Z - 4 days ago

DexCom price target raised to $92 from $86 at Deutsche Bank


DexCom price target raised to $94 from $91 at Raymond James

2026-07-31T12:36:49.000Z - 4 days ago

DexCom price target raised to $94 from $91 at Raymond James


DexCom price target raised to $90 from $80 at BTIG

2026-07-31T12:06:10.000Z - 4 days ago

DexCom price target raised to $90 from $80 at BTIG


DexCom price target raised to $82 from $77 at Benchmark

2026-07-31T12:05:47.000Z - 4 days ago

DexCom price target raised to $82 from $77 at Benchmark


DexCom price target raised to $95 from $88 at Piper Sandler

2026-07-31T11:38:20.000Z - 4 days ago

DexCom price target raised to $95 from $88 at Piper Sandler


DexCom price target raised to $95 from $90 at Mizuho

2026-07-31T11:31:21.000Z - 4 days ago

DexCom price target raised to $95 from $90 at Mizuho


DexCom price target raised to $82 from $65 at JPMorgan

2026-07-31T11:26:07.000Z - 4 days ago

DexCom price target raised to $82 from $65 at JPMorgan


DexCom price target raised to $105 from $80 at Baird

2026-07-31T11:20:53.000Z - 4 days ago

DexCom price target raised to $105 from $80 at Baird


DexCom price target raised to $95 from $90 at Stifel

2026-07-31T11:20:30.000Z - 4 days ago

DexCom price target raised to $95 from $90 at Stifel


DexCom price target raised to $88 from $84 at Citi

2026-07-31T10:45:45.000Z - 4 days ago

DexCom price target raised to $88 from $84 at Citi


DexCom Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 5 days ago

DexCom Earnings Call Transcript: Q2 2026


DexCom Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 5 days ago

DexCom Slides: Q2 2026


DexCom Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 5 days ago

DexCom Earnings release: Q2 2026


DexCom Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 5 days ago

DexCom Quarterly report: Q2 2026


DexCom reports Q2 EPS 70c, consensus 61c

2026-07-30T20:17:35.000Z - 5 days ago

DexCom reports Q2 EPS 70c, consensus 61c


DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B

2026-07-30T20:17:18.000Z - 5 days ago

DexCom sees FY25 revenue $5.15B-$5.25B, consensus $5.22B


Dexcom Reports Second Quarter 2026 Financial Results

Jul 30, 2026, 4:02 PM EDT - 5 days ago

Dexcom Reports Second Quarter 2026 Financial Results


DexCom resumed with a Buy at UBS

2026-07-28T11:56:11.000Z - 7 days ago

DexCom resumed with a Buy at UBS


Dexcom Further Advances Vision of Glucose Biosensing for All

Jun 23, 2026, 9:00 AM EDT - 6 weeks ago

Dexcom Further Advances Vision of Glucose Biosensing for All


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 6 weeks ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


FDA clears first over-the-counter glucose monitor for children

Jun 12, 2026, 4:15 PM EDT - 7 weeks ago

FDA clears first over-the-counter glucose monitor for children


Dexcom warns patients as stolen glucose sensors hit the market

May 26, 2026, 10:47 AM EDT - 2 months ago

Dexcom warns patients as stolen glucose sensors hit the market


DexCom Transcript: Investor Day 2026

May 14, 2026, 4:15 PM EDT - 2 months ago

DexCom Transcript: Investor Day 2026


DexCom Slides: FY 2026

May 14, 2026, 4:15 PM EDT - 2 months ago

DexCom Slides: FY 2026


Dexcom to Host Investor Day on May 14, 2026

May 5, 2026, 8:30 AM EDT - 3 months ago

Dexcom to Host Investor Day on May 14, 2026


DexCom Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

DexCom Earnings Call Transcript: Q1 2026


DexCom Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

DexCom Earnings release: Q1 2026


DexCom Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

DexCom Slides: Q1 2026


DexCom Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 3 months ago

DexCom Quarterly report: Q1 2026


Dexcom Reports First Quarter 2026 Financial Results

Apr 30, 2026, 4:02 PM EDT - 3 months ago

Dexcom Reports First Quarter 2026 Financial Results


DexCom Slides: Investor presentation

Apr 30, 2026, 7:00 AM EDT - 3 months ago

DexCom Slides: Investor presentation


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

DexCom Proxy statement: Proxy filing


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

DexCom Proxy statement: Proxy filing


Dexcom Appoints Rick Osterloh to Board of Directors

Feb 26, 2026, 4:15 PM EST - 5 months ago

Dexcom Appoints Rick Osterloh to Board of Directors


Dexcom Announces Upcoming Conference Presentation

Feb 25, 2026, 8:30 AM EST - 5 months ago

Dexcom Announces Upcoming Conference Presentation


The Big 3: VZ, DXCM, AMAT

Feb 19, 2026, 1:00 PM EST - 5 months ago

The Big 3: VZ, DXCM, AMAT

AMAT VZ


DexCom Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Earnings Call Transcript: Q4 2025


DexCom Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Annual report: Q4 2025


DexCom Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Earnings release: Q4 2025


DexCom Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 6 months ago

DexCom Slides: Q4 2025


DexCom Slides: Investor presentation

Feb 12, 2026, 7:00 AM EST - 6 months ago

DexCom Slides: Investor presentation


Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 7 months ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach


DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 7 months ago

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference


DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 7 months ago

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference


Mobagri
Mobagri Aug. 4 at 2:06 PM
$DXCM https://www.marketscreener.com/news/argus-adjusts-price-target-on-dexcom-to-96-from-86-maintains-buy-rating-ce7f50deda80f320
0 · Reply
MaxDillon_
MaxDillon_ Aug. 3 at 10:53 PM
Wall Street Analyst Rating Updates: Key Target Shifts! • $DT: Cantor raises target to $47 (from $37), Overweight (Trading at $44.54) • $DXCM: Canaccord lifts target to $90 (from $82), Buy (Trading at $87.31). • $EBAY: Bernstein reiterates $115 Market Perform; Wells Fargo cuts target to $92 and downgrades to Underweight (Trading at $114.01). Diverging analyst sentiment creates key entry and exit divergences for smart capital.Are you buying the $DXCM momentum or shorting$EBAY's downgrade?
0 · Reply
Mobagri
Mobagri Aug. 3 at 3:40 PM
$DXCM we close at $89 today
1 · Reply
Mobagri
Mobagri Aug. 3 at 3:39 PM
$DXCM https://www.marketscreener.com/news/ubs-adjusts-price-target-on-dexcom-to-102-from-96-maintains-buy-rating-ce7f50d9da89f12d
0 · Reply
RobertMickey186
RobertMickey186 Aug. 3 at 2:47 PM
$JBL $ZTS $MLM $VG $DXCM Jabil benefits from electronics manufacturing, Zoetis leads animal health, Martin Marietta gains from construction demand, Venture Global benefits from LNG exports, and DexCom dominates continuous glucose monitoring.
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:49 PM
$DXCM https://www.marketscreener.com/news/rothschild-co-redburn-adjusts-price-target-on-dexcom-to-100-from-90-maintains-buy-rating-ce7f50d9db89f025
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:43 PM
$DXCM going towards $93 faster than I thought
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:08 PM
$DXCM yop
0 · Reply
Mobagri
Mobagri Aug. 3 at 1:06 PM
$DXCM huge buying by investment funds
0 · Reply
m322m
m322m Aug. 2 at 8:38 PM
$DXCM best mode 💚
0 · Reply
MaxDillon_
MaxDillon_ Aug. 2 at 2:56 PM
$DXCM exploded +12% on Friday following a strong Q2 double beat & raised guidance! As healthcare sentiment in $SPY heats up, Dexcom is riding heavy volume buying after expanding margins and boosting its full-year outlook. While short-term selling into strength is hitting resistance around $83$85, a sustained close above $85 could spark a push toward 52-week highs.
0 · Reply
topstockalerts
topstockalerts Jul. 31 at 10:35 PM
Stifel named DexCom its top investment idea in the medical technology and supplies sector after the diabetes device maker delivered stronger-than-expected Q2 2026 results and raised its full-year outlook. The company beat expectations across revenue, gross margin, operating margin, and EPS, while increasing guidance for both organic revenue growth and profitability. Stifel said management’s comments on market share gains align with its proprietary survey data, suggesting DexCom has achieved sustained U.S. market share gains for the first time in years. The firm believes the company still has multiple growth catalysts despite the stock’s strong rally since its May Investor Day, including the large untapped Type 2 diabetes market among non-insulin users, with commercialization expected by late 2026 and broader insurance coverage anticipated by mid-2027. $DXCM
0 · Reply
Optimist420
Optimist420 Jul. 31 at 10:05 PM
$DXCM Wow it's been a while since we've seen a 12% day here. I sold dxcm a few years ago at the top. Looking good again I may take a small position soon.
0 · Reply
topstockalerts
topstockalerts Jul. 31 at 9:43 PM
$DXCM not chasing but definitely watching this closely
0 · Reply
Mobagri
Mobagri Jul. 31 at 9:07 PM
$DXCM Friday is a slow day. This will pick up on Monday all the way to $90’s
0 · Reply
anvesti
anvesti Jul. 31 at 7:45 PM
Anvesti closed a long position $DXCM 🟢 +21.46% $68.82 → $83.59 Model: ml_model_v2 · Score: 82.8 Reason: Profit Target · 28 days
0 · Reply
T7_Hldg_Partner
T7_Hldg_Partner Jul. 31 at 7:31 PM
$DXCM long term holder. Will continue to do so.
0 · Reply
TwinTurboBul161
TwinTurboBul161 Jul. 31 at 5:21 PM
$DXCM looking great today
0 · Reply
Chrissytina
Chrissytina Jul. 31 at 5:16 PM
$DXCM We hit the lowest raised target price today!!! 😁 There’s more to come!!! So…👇🏻
0 · Reply
Stocktwits52wHighs
Stocktwits52wHighs Jul. 31 at 5:01 PM
$DXCM printed a new 52-week high today
0 · Reply
runitback349
runitback349 Jul. 31 at 5:00 PM
$DXCM not a day trading stock. Doesn’t move fast. Great investment even if getting in today. Nice guidance raise. Potential growth acceleration?
0 · Reply